Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Pre-market Movers For Feb 29 (VRSK, LIZ, FSLR, TTEC, PANL, SODA, CEDC, NKTR)

RELATED NEWS
Trade FSLR now with 

Gainers:

Verisk Analytics, Inc. (VRSK: Quote) is up 9 percent to $46.00. The company's fourth quarter profit rose nearly 22 percent from the year-ago quarter. Total revenue increased 19.9 percent for the fourth quarter.

Liz Claiborne, Inc. (LIZ: Quote) is up over 2 percent to $10.65. The company swung to a profit in its fourth quarter. Net sales declined 2.6 percent. The company reaffirmed its 2012 adjusted EBITDA guidance of $125 million to $140 million, excluding foreign currency transaction gains or losses.

Decliners:

First Solar, Inc. (FSLR: Quote) is falling 6 percent to $34.20 as the company has slipped to a loss in its fourth quarter. The company also lowered its fiscal 2012 net sales guidance, while reiterating earnings per share forecast.

TeleTech Holdings, Inc. (TTEC: Quote) is down 12 percent to $15.55 as the company's fourth quarter earnings and revenue were below Wall Street view. The company also guided 2012 revenue below consensus.

Universal Display Corp. (PANL: Quote) is down nearly 6 percent to $43.06 as the company forecast full year 2012 revenue below analysts' estimate. However, the company reported a profit for its fourth quarter, with both earnings per share and revenues coming in above consensus estimates.

SodaStream International Ltd. (SODA: Quote) is falling 12 percent to $41.68. The company's fourth quarter profit and revenue improved from the year-ago quarter. The company expects full year 2012 revenue to increase approximately 28 percent and net income to increase by approximately 42 percent.

Central European Distribution Corp. (CEDC: Quote) is down 29 percent to $3.85. The company's fourth quarter loss widened from the previous year period. Comparable earnings per share and net sales were sharply below consensus.

Trading halt:

Trading in shares of Nektar Therapeutics (NKTR: Quote) was halted. The company announced agreement to sell CIMZIA and MIRCERA royalties to Royalty Pharma for $124 Million. The company is slated to report its fourth quarter results today after the market close.

Register
To receive FREE breaking news email alerts for First Solar, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The Swiss economy stalled in the second quarter as the improvement in household spending was insufficient to offset the weakness in exports and investment in construction. Gross domestic product remained flat from the first quarter, when it accelerated to 0.5 percent, the State Secretariat for Economic Affairs said Tuesday. Economists had expected GDP to rise 0.5 percent in the second quarter. Policymakers of Reserve Bank of Australia decided to maintain its record low interest rate once again as they continue to assess that the most prudent course is a period of stability in interest rates. The monetary policy board retained the cash rate at 2.50 percent. The rate has been at the current level since August 2013. A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.